Your session is about to expire
← Back to Search
Behavioral Intervention
Cognitive Behavioral Therapy for Social Anxiety Disorder
N/A
Recruiting
Led By Daniel F Gros, PhD MA BS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to week 6 to week 12 to 6-month followup
Awards & highlights
Study Summary
This trial aims to assess the effectiveness of a therapy (TBT) for Veterans with anxiety/depression disorders, compared to an existing therapy (DST). Assessments will be done before/during/after treatment & 6mos later.
Who is the study for?
This trial is for Veterans registered at Ralph H. Johnson VA Health Care System who have been diagnosed with social anxiety disorder and also show symptoms of posttraumatic stress. They must be able to give informed consent. Specific details on who can't join are not provided.Check my eligibility
What is being tested?
The study compares Transdiagnostic Behavior Therapy (TBT), a versatile treatment for various disorders, with Cognitive Behavioral Therapy (CBT) specifically designed for Social Anxiety Disorder in treating veterans with both conditions.See study design
What are the potential side effects?
Since the interventions involve therapy sessions rather than medication, typical side effects associated with drugs may not apply here. However, participants might experience emotional discomfort or distress during therapy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to week 6 to week 12 to 6-month followup
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to week 6 to week 12 to 6-month followup
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Illness Intrusiveness Rating Scale (IIRS)
MASA functional impairment
PTSD Checklist for DSM-5 (PCL-5)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Transdiagnostic Behavior TherapyExperimental Treatment1 Intervention
TBT was developed to address transdiagnostic avoidance via the use of four different types of exposure techniques (situational/in-vivo, physical/interoceptive, thought/imaginal, and [positive] emotional/behavioral activation). From the transdiagnostic avoidance perspective, the four exposure practices are matched to the type(s) of avoidance experienced by patients based upon their cluster of symptoms/disorders.
Group II: Cognitive Behavioral Therapy for Social Anxiety DisorderActive Control1 Intervention
To provide an evidence-based comparison for the TBT condition, the research-supported psychological treatment of CBT for SAD will be used. CBT for SAD demonstrates efficacy in improving SAD symptoms and quality of life for patients with SAD, with durable improvements evidenced at follow-up assessments. CBT for SAD was used as a comparison to TBT in previous preliminary research. CBT for SAD involves several primary components, including: 1) psychoeducation, 2) training in cognitive restructuring, 3) exposures, 4) advanced cognitive restructuring, and 5) termination.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transdiagnostic Behavior Therapy
2014
N/A
~110
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,305,020 Total Patients Enrolled
Daniel F Gros, PhD MA BSPrincipal InvestigatorRalph H. Johnson VA Medical Center, Charleston, SC
3 Previous Clinical Trials
615 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I started new psychiatric medication less than 4 weeks ago.I understand and can consent to participate in research.I experience significant symptoms from PTSD.
Research Study Groups:
This trial has the following groups:- Group 1: Transdiagnostic Behavior Therapy
- Group 2: Cognitive Behavioral Therapy for Social Anxiety Disorder
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Could I be a participant in this clinical trial?
"This study is accepting up to 264 participants who have been diagnosed with social anxiety disorder, and must be between 18-80 years of age."
Answered by AI
Is this study available to those in the geriatric age bracket?
"The requirements for enrolment stipulate that prospective participants range between 18 to 80 years old. On the other hand, there are 339 clinical trials available specifically targeting patients under 18 and 893 catering to those above 65."
Answered by AI
Are recruits currently being accepted for this experiment?
"According to records on clinicaltrials.gov, this trial is no longer actively recruiting; the original posting was April 1st 2024 and it has been edited as recent as May 10th 2023. Nonetheless, 1311 other trials are still open for enrolment at the moment."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger